<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-12-22">December 22, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Piotr</forename><surname>Popławski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="department" key="dep2">Centre of Postgraduate Medical Education</orgName>
								<address>
									<settlement>Warsaw</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jacek</forename><forename type="middle">R</forename><surname>Wiśniewski</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Biochemical Proteomics Group</orgName>
								<orgName type="institution">Max-Planck-Institute of Biochemistry</orgName>
								<address>
									<settlement>Martinsried</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eddy</forename><surname>Rijntjes</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institut fu ¨r Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Keith</forename><surname>Richards</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institut fu ¨r Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Beata</forename><surname>Rybicka</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="department" key="dep2">Centre of Postgraduate Medical Education</orgName>
								<address>
									<settlement>Warsaw</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Josef</forename><surname>Ko ¨hrle</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institut fu ¨r Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Agnieszka</forename><surname>Piekiełko-Witkowska</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="department" key="dep2">Centre of Postgraduate Medical Education</orgName>
								<address>
									<settlement>Warsaw</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">University</orgName>
								<address>
									<addrLine>Claude Bernard Lyon 1</addrLine>
									<country key="FR">FRANCE</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-12-22">December 22, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">8C0AFFB0774160E143DC5AF941EFC885</idno>
					<idno type="DOI">10.1371/journal.pone.0190179</idno>
					<note type="submission">Received: August 28, 2017 Accepted: December 8, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:27+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Type 1 iodothyronine deiodinase (DIO1) contributes to deiodination of 3,5,3',5'-tetraiodo-Lthyronine (thyroxine, T4) yielding of 3,5,3'-triiodothyronine (T3), a powerful regulator of cell differentiation, proliferation, and metabolism.</s><s>Our previous work showed that loss of DIO1 enhances proliferation and migration of renal cancer cells.</s><s>However, the global effects of DIO1 expression in various tissues affected by cancer remain unknown.</s><s>Here, the effects of stable DIO1 re-expression were analyzed on the proteome of renal cancer cells, followed by quantitative real-time PCR validation in two renal cancer-derived cell lines.</s><s>DIO1-induced changes in intracellular concentrations of thyroid hormones were quantified by L-MS/MS and correlations between expression of DIO1 and potential target genes were determined in tissue samples from renal cancer patients.</s><s>Stable re-expression of DIO1, resulted in 26 downregulated proteins while 59 proteins were overexpressed in renal cancer cells.</s><s>The 'downregulated' group consisted mainly of oncoproteins (e.g.</s><s>STAT3, ANPEP, TGFBI, TGM2) that promote proliferation, migration and invasion.</s><s>Furthermore, DIO1 re-expression enhanced concentrations of two subunits of thyroid hormone transporter (SLC7A5, SLC3A2), enzymes of key pathways of cellular energy metabolism (e.g.</s><s>TKT, NAMPT, IDH2), sex steroid metabolism and anti-oxidative response (AKR1C2, AKR1B10).</s><s>DIO1 expression resulted in elevated intracellular concentration of T4.</s><s>Expression of DIO1-affected genes strongly correlated with DIO1 transcript levels in tissue samples from renal cancer patients as well as with their poor survival.</s><s>This first study addressing effects of deiodinase re-expression on proteome of cancer cells demonstrates that induced DIO1 re-expression in renal cancer robustly downregulates oncoproteins, affects key metabolic pathways, and triggers proteins involved in anti-oxidative protection.</s><s>This data supports the notion that suppressed DIO1 expression and changes in local availability of thyroid hormones might favor a shift from a differentiated to a more proliferation-prone state of cancer tissues and cell lines.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney tumors, affecting more than 300,000 people annually worldwide <ref type="bibr" target="#b0">[1]</ref>.</s><s>The key molecular alteration in ccRCC pathology is inactivation of VHL tumor suppressor that leads to persistent activation of hypoxia-induced transcription factors (HIFs), resulting in induction of proliferation, invasion and angiogenesis <ref type="bibr" target="#b1">[2]</ref>.</s><s>Recent findings indicate that tumorous phenotype of ccRCC is largely driven by alterations in cellular metabolism <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>.</s><s>They include Warburg effect, the universal feature of cancer cells, that is defined as increased consumption of glucose which is largely converted to lactate, even under normoxic conditions, as well as activated pentose phosphate pathway (PPP), suppressed TCA cycle, enhanced lipogenesis and metabolism of amino acids <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s>These changes are interpreted as a metabolic reprogramming that enables efficient production of essential building blocks (nucleotides, lipids, amino acids) required to sustain intensive proliferation of cancer cells.</s><s>This metabolic shift also provides large amounts of metabolites which contribute to cellular buffering system and protection against acidic environment and oxidative stress of tumors <ref type="bibr" target="#b5">[6]</ref>.</s></p><p><s>Type 1 iodothyronine deiodinase (DIO1) is one of the three enzymes regulating bioavailability of thyroid hormones in thyroid and extrathyroid tissues <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s>By catalyzing deiodination of thyroxine (T4), DIO1 can contribute to the synthesis of 3,5,3'triiodo-L-thyronine (T3), a powerful regulator of cellular differentiation, proliferation, metabolism, and apoptosis acting via classical T3 receptors and non-classical rapid signaling <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>.</s><s>The expression of deiodinase isoenzymes (DIO1, DIO2, DIO3) is altered in cancers, providing dynamic changes in intracellular steady state T3 concentrations which impact on the expression of T3-dependent genes and contribute to processes involved in cancerogenesis.</s><s>Previous studies on DIO2 and DIO3 in colon cancer and basal cell carcinoma revealed that their altered enzyme activities caused changes in expression of genes involved in tumor development, progression and apoptosis <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>.</s><s>Our recent work revealed that reduced expression of DIO1 in renal cancer contributes to altered expression of genes controlling cell cycle progression, adhesion and migration, with marked impact on proliferation and cell motility <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>.</s><s>Remarkably, although the regulation of DIO1 expression is relatively well understood <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>, the global effects of DIO1 expression in cancer remain unknown.</s><s>Considering the importance of T3 in the regulation of cellular metabolism, one can also expect, that changes in DIO1 expression could affect metabolic pathways in ccRCC tumors.</s></p><p><s>To get more mechanistic insight into the effects of DIO1 expression in cancer cells, the current study reports on proteomic analysis of renal cancer cells which were stably transfected by a vector expressing DIO1.</s><s>The presence of DIO1 activity in renal cancer cells introduces major changes in cellular proteome, affecting i) the key metabolic pathways that are altered in ccRCC tissues, ii) the elements of the anti-oxidative system as well as iii) expression levels of proteins that drive oncogenic transformation of renal cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human cell lines</head><p><s>KIJ265T and KIJ308T cell lines, derived from ccRCC, were obtained from Mayo Foundation for Medical Education and Research <ref type="bibr" target="#b24">[25]</ref> and cultured as described previously <ref type="bibr" target="#b25">[26]</ref>.</s><s>Preparation of cells stably transfected with pcDNA3-DIO1 plasmid (kindly provided by T.J. Visser, <ref type="bibr" target="#b26">[27]</ref>) or with an empty vector, was described previously <ref type="bibr" target="#b20">[21]</ref>.</s><s>Expression of DIO1 was determined by qPCR and Western blot.</s></p><p><s>For intracellular hormone measurements, KIJ265T-DIO1(+) and KIJ265-DIO1(-) cells were cultured in medium without phenol red supplemented with 10% FBS (Sigma-Aldrich, St. Louis, MO, USA) for 7 days.</s><s>The mean T4 and T3 concentrations in FBS-supplemented cell culture medium was 26.2 nM and 0.069 nM, respectively, which is within the range of concentrations reported previously <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref>.</s><s>Next, cells were seeded on 6-well plates at density 1.25×10 5 per well and the medium was renewed after 24h.</s><s>The cells were cultured for the next 24h with medium renewal after 24h.</s><s>Following the next 24h, the medium was collected, and the plates with adhered cells were put on ice, washed with ice-cold PBS and stored in -80˚C until analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Thyroid hormone analysis</head><p><s>The sample preparation and analysis of supernatants of cell culture medium <ref type="bibr" target="#b30">[31]</ref> and cells <ref type="bibr" target="#b31">[32]</ref> has been previously described.</s><s>In brief, cell culture plate wells containing dry cells were treated with lysis buffer (0.1 N sodium hydroxide and homogenization buffer 50:50% v/v, 200 μL) on ice for 3 min with shaking; 30% v/v acetic acid in homogenization buffer (100 μL) was then added.</s><s>Cell culture medium supernatants (400 μL) were acidified with 37% HCl (5 μL).</s><s>Both cell lysates and cell culture medium supernatants were spiked with a mixture of internal standards (for supernatants: in 5 μL DMSO, for cell lysates: in 100 μL in DMSO: methanol: water 5:45:45% v/v/ v containing 0.1% formic acid) composed of isotopically-labelled 3,3-T 2 , T 3 , rT 3 ,T 4 , 3-T 1 AM, T 0 Ac and T 1 Ac at a final concentration of 100 nM.</s><s>Internal standard-spiked supernatant or cell lysates were then incubated at 37˚C for 60 min, then twice liquid-liquid extracted (2 x 1 mL of 30% v/v 2-propanol in t-butyl methyl ether, combining the 2 x 1mL extracts).</s><s>The extracts were evaporated to dryness, then re-constituted in 50:50% v/v methanol: water containing 0.1% formic acid (100 μL).</s><s>40 μL of extract was injected into a Sciex API 6500 QTRAP LC-MS/MS system equipped with a 100 x 3 mm Waters X-Select HSS PFP column, running a water (UHP, 18.2 mΩ) /methanol (containing 0.1% formic acid) gradient.</s><s>The mass spectrometer was operated in electrospray positive ionization mode using multiple reaction monitoring (MRM).</s><s>Data was acquired and processed with Analyst™ 1.6.2 and MultiQuant™ 2.11 software.</s><s>Linear calibration curves in cell culture medium were obtained in the range from 0.0125 to 250 nM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Proteomic analysis</head><p><s>For protein isolations, the cells were seeded on 6-well plates at density of 1.25 × 10 5 cells per well and cultured for 72 hours.</s><s>Medium was removed and cells were rinsed 3 times with PBS without calcium and magnesium (Thermo Fisher Scientific, Rockford, IL, USA).</s><s>Next, cells were lysed with 500 μl of protein isolation buffer (0.1M Tris pH 7.5, 2% SDS, 0.1M DTT) and boiled for 5 min.</s><s>Protein lysates were processed using the MED/FASP procedure and the resulting peptide digests were analyzed as described previously <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b33">34]</ref>.</s><s>Total protein in the SDS lysates and peptide concentration in the digests were determined using the WF assay <ref type="bibr" target="#b34">[35]</ref>.</s><s>Titers of protein were calculated by the 'total protein approach' using the raw spectral intensities from MaxQuant output <ref type="bibr" target="#b35">[36]</ref>.</s></p><p><s>Protein enrichment analysis and classification according to molecular functions, cellular localizations and classes was performed using http://www.geneontology.org/</s><s><ref type="bibr" target="#b36">[37]</ref> powered by Protein Analysis Through Evolutionary Relationships (PANTHER) <ref type="bibr" target="#b37">[38]</ref>.</s><s>Protein-protein interaction network was generated using STRING v. 10.5 with default settings (minimum required interaction score: medium confidence 0.4) <ref type="bibr" target="#b38">[39]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of RNA and cDNA synthesis</head><p><s>For RNA isolations, the cells were seeded on 12-well plates at density of 5 × 10 4 cells per well and cultured for 72 hours.</s><s>RNA was isolated using GeneMATRIX Universal RNA Purification Kit (EURx, Gdańsk, Poland) and reverse transcription was performed as described previously <ref type="bibr" target="#b20">[21]</ref>.</s></p><p><s>RNA samples from human ccRCC and matched-paired control tissues not infiltrated by tumor were obtained from the RNA Bank deposited at the Centre of Postgraduate Medical Education at the Department of Biochemistry and Molecular Biology (approved by the local Bioethical Committee: no.</s><s>18/PB/2012 and no.</s><s>75/PB-A/2014).</s><s>1000 ng of RNA was reverse transcribed as described previously <ref type="bibr" target="#b20">[21]</ref> with Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Mannheim, Germany) using random hexamer primers and anchoredoligo(dT) <ref type="bibr" target="#b17">18</ref> .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Real-time quantitative PCR</head><p><s>Real-time quantitative PCR (qPCR) was performed on LightCycler1 480 (Roche Diagnostics) using primers and probes given in S1 Table and SYBR Green I Master (Roche Diagnostics) or TaqManUniversal Master MiX II with UNG (Thermo Fisher Scientific), according to producers protocols.</s><s>Reference genes for normalization were chosen using Normfinder tool <ref type="bibr" target="#b39">[40]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Protein isolation and Western blotting</head><p><s>Protein isolations were performed as described previously <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b40">41]</ref>.</s><s>60 μg of proteins was resolved using 10% SDS-PAGE and Western blot analysis was performed as described previously <ref type="bibr" target="#b20">[21]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Survival analysis</head><p><s>Survival rate analysis was performed as described previously <ref type="bibr" target="#b40">[41]</ref> using the SurvExpress platform <ref type="bibr" target="#b41">[42]</ref> on transcriptomic data of independent cohort of ccRCC patients, retrieved from TCGA (Cancer Genome Atlas Network, https://tcga-data.nci.nih.gov,</s><s><ref type="bibr" target="#b42">[43]</ref>).</s><s>The median follow up of the 468 TCGA ccRCC patients was 43.2 months.</s><s>The relationship between the gene expression and survival time was estimated using Cox Proportional Hazard regression.</s><s>Two risk groups were generated using the prognostic index median.</s><s>The equality of survival curves was evaluated using log-rank test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analysis was performed with GraphPad Prism 5.00 for Windows (GraphPad Software, San Diego, CA, USA) using the Shapiro-Wilk normality test, Wilcoxon matched pair signed rank test, paired t-test and Spearman rank correlation test.</s><s>p&lt;0.05 was considered statistically significant.</s></p><p><s>In proteomic analysis non-paired Student's t-test was used for comparisons between two experimental groups.</s><s>The maximal number of 0-values per group was 2. The missing values were imputed using the parameter values of 0.3 for width and 1.8 for down shift.</s><s>p&lt;0.05 was considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identification and quantitative analysis of proteins affected by DIO1 expression</head><p><s>Induction of DIO1 expression was confirmed using Western blot (S1 Fig) <ref type="figure">.</ref></s><s>Proteomic analysis of KIJ265T-DIO1(+) and KIJ265T-DIO1(-) cells identified peptides derived from 4761 proteins (S2 Table <ref type="table">)</ref>.</s><s>Differential analysis revealed 85 proteins that were differently expressed in KIJ265T-DIO1(+) cells when compared with KIJ265T-DIO1(-) cells (False Discovery Rate&lt;0.05,</s><s>p&lt;0.05).</s><s>Among these proteins, 26 were upregulated (Table <ref type="table" target="#tab_0">1</ref>), while 59 were downregulated (Table <ref type="table" target="#tab_2">2</ref>) in DIO1(+) cells.</s><s>Top upregulated proteins included AKR1C2 (+57 fold), RAP1GAP (+15.8 fold), and AKR1B10 (+8.2 fold).</s><s>Top proteins with decreased expression included AFAP1L2 (-31.2 fold), ANPEP (-8.7 fold), and CYR61 (-8.2 fold).</s><s>Remarkably, among the proteins with expression increased there were two subunits of LAT1 transporter (SLC7A5 (+3.66 fold) and SLC3A2 (+1.73 fold)) that is involved in intracellular transport of amino acids and thyroid hormones <ref type="bibr" target="#b43">[44]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Classification of proteins affected by DIO1 expression</head><p><s>Functional analysis using PANTHER revealed that DIO1 expression affected proteins involved in key metabolic and cellular processes (Fig <ref type="figure" target="#fig_2">1</ref>).</s><s>The key affected pathways were linked with metabolism of proteins, nucleobase-containing compounds, and carbohydrates (Fig <ref type="figure">2</ref>).</s><s>Consistently, the most prominent classes of proteins affected by DIO1 expression featured activities of hydrolases, oxidoreductases and transferases (Fig <ref type="figure">3</ref>).</s></p><p><s>To get further insight into the functions of differentially expressed proteins, functional enrichment analysis was performed separately on groups of upregulated and downregulated The table shows results of proteomic analysis performed in KIJ265T cells transfected with pcDNA3-DIO1 or empty plasmid.</s><s>Only proteins of which levels were statistically significantly increased in DIO1 expressing cells (DIO1+) when compared with cells transfected with an empty plasmid (DIO1-) are shown (threshold: 1.3-fold change, FDR&lt;0.05,</s><s>p&lt;0.05).</s><s>The raw proteomic data are given in S2</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NMT2</head><p><s>Glycylpeptide N-tetradecanoyltransferase 2; Glycylpeptide N-tetradecanoyltransferase -6.80 6.43×10 -4</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MICAL3</head><p><s>Protein-methionine sulfoxide oxidase MICAL3 -5.04 1.72×10 proteins using PANTHER.</s><s>This analysis revealed striking homogeneity of both groups of proteins.</s><s>GO categorization under 'biological processes' indicated that UPREGULATED group was enriched in proteins mainly involved in metabolic regulation, while DOWNREGULATED group was enriched in proteins involved in adhesion (Table <ref type="table">3</ref>).</s><s>This was further confirmed by categorization under 'molecular function' that showed that UPREGULATED proteins were enriched in various enzymatic activities including reductases, dehydrogenases and oxidoreductases activities, while DOWNREGULATED group was characterized by cadherin binding and cell adhesion binding (Table <ref type="table">3</ref>).</s><s>Cellular component analysis showed that UPREGULATED proteins were mainly related to extracellular exosome, extracellular vesicle, and organelle, while DOWNREGULATED group was enriched in proteins associated with lamellipodium, focal adhesion and other cell components involved in cell-cell and cell-ECM contacts (Table <ref type="table">3</ref>).</s><s>Next, we analyzed possible functional links between the proteins affected by DIO1 expression.</s><s>Correlation matrix analysis revealed that the expressions of proteins were highly correlated (Fig 4 and S4 Table <ref type="table">)</ref>, confirming that their expressions were coordinately changed following DIO1 expression.</s><s>Protein interaction network generated with STRING tool revealed three major clusters of proteins, involved in cytoskeleton remodeling and intracellular trafficking, cellular adhesion, and metabolism (Fig <ref type="figure" target="#fig_4">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Validation of proteomic analysis</head><p><s>To validate the results of proteomic analysis, expressions of ten genes encoding proteins affected by DIO1 expression were verified using qPCR in two RCC-derived cell lines, KIJ265T and KIJ308T, with or without ectopic expression of DIO1.</s><s>The expressions of all ten genes were changed in accordance with the results of proteomic analysis (Fig <ref type="figure" target="#fig_5">5</ref>).</s><s>Specifically, the</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AKR1B1</head><p><s>Aldose reductase -1.42 3.84×10 -5</s></p><formula xml:id="formula_0">AP3B1 AP-3 complex subunit beta-1 -1.31 1.74×10 -4</formula><p><s>The table shows results of proteomic analysis performed in KIJ265T cells transfected with pcDNA3-DIO1 or empty plasmid.</s><s>Only proteins of which levels were statistically significantly decreased in DIO1 expressing cells (DIO1+) when compared with cells transfected with an empty plasmid (DIO1-) are shown  The expressions of DIO1-affected genes correlate with DIO1 transcript concentration in renal cancer tissues</s></p><p><s>To check if genes affected by DIO1 expression could be linked with altered DIO1 function in renal tumors, we analyzed their expressions in tissue samples derived from 30 patients with ccRCC.</s><s>As previously reported <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>, the expression of DIO1 transcript was markedly decreased in renal tumors (S3 Fig) <ref type="figure">.</ref></s><s>Furthermore, the expression of the vast majority of analyzed genes was altered in tumor samples when compared with control samples (Fig <ref type="figure" target="#fig_6">6</ref>).</s><s>Specifically, the transcript expressions of AKR1C1, S100A2, PLAU, SLC3A2, TBC1D2, and WIZ were decreased, while expressions of TGM2, SLC7A5, and NMI were increased in renal tumors when compared with non-tumorous control samples (Fig <ref type="figure" target="#fig_6">6</ref>).</s><s>The expression of AKR1C2 was not statistically significantly changed in ccRCC tumors.</s><s>Next, we evaluated the possible correlations between the expressions of DIO1 and its affected genes.</s><s>Strikingly, the transcript expressions of most genes (except for AKR1C2 and SLC7A5) strongly correlated with DIO1 levels in analyzed tissue samples (Fig <ref type="figure" target="#fig_7">7</ref>).</s><s>Specifically, the expressions of AKR1C1, PLAU, S100A2, TBC1D2, WIZ, and SLC3A2 were positively correlated (r Spearman ranging from 0.34 for WIZ to 0.82 for SLC3A2) while expressions of TGM2  and NMI were negatively correlated with DIO1 levels (r Spearman: -0.53, and -0.44, respectively) (Fig <ref type="figure" target="#fig_7">7</ref>).</s><s>In case of AKR1C1, TGM2, NMI, and SLC3A2, these correlations corresponded well with the direction of DIO1-induced changes of expression (Fig <ref type="figure" target="#fig_5">5</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Altered expression of DIO1-affected genes correlates with poor survival of ccRCC patients</head><p><s>Next, we evaluated the possible links between the expression of DIO1-affected genes and ccRCC progression.</s><s>To this end, we took advantage of the publically available data of The Cancer Genome Atlas (TCGA, <ref type="bibr" target="#b42">[43]</ref>).</s><s>This analysis, performed on transcriptomic data of 468 patients, showed that altered expressions of AKR1C1, AKR1C2, SLC7A5, NMI, PLAU, TBC1D2, TGM2, and WIZ correlated with poor survival of ccRCC patients.</s><s>There was no such correlation for SLC3A2, while for S100A2 the correlation with survival of patients was on the border of statistical significance (Fig <ref type="figure">8</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Induced DIO1 expression affects intracellular level of thyroxine</head><p><s>Finally, to see if the ectopic DIO1 expression influenced the levels of thyroid hormones, we measured intracellular concentrations of T4 and T3.</s><s>T3 measurements were below of the detection limit.</s><s>However, in agreement with enhanced transcript expression of LAT1 transporter subunits, we observed a substantial increase in cellular concentration of T4 (Fig <ref type="figure">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>To our knowledge, this is the first study addressing the effects of altered iodothyronine deiodinase expression at the proteome level.</s><s>In our previous report we found that restoration of DIO1 expression in renal cancer cells inhibits their proliferation and migration <ref type="bibr" target="#b20">[21]</ref>.</s><s>Now we show that induction of DIO1 expression in renal cancer cells leads to profound changes in cellular proteome and affects the expression of genes and proteins involved in metabolic regulation, oxidative stress, autophagy and adhesion.</s><s>Remarkably, altered expression of genes encoding proteins affected by DIO1 re-expression correlates with poor survival of renal cancer patients.</s><s>We also demonstrate that DIO1 expression induces expression of both subunits of the thyroid hormone transporter LAT1 and increases intracellular T4 concentrations.</s><s>ccRCC is a metabolic disease <ref type="bibr" target="#b5">[6]</ref>.</s><s>The key modifications of ccRCC metabolism include Warburg effect, activation of pentose phosphate pathway (PPP), suppression of TCA cycle, and activation of lipogenesis.</s><s>These changes provide cancer cells with high amounts of compounds (e.g.</s><s>nucleotides, amino acids, lipids) that can serve as 'building blocks' for intensively proliferating cells.</s><s>In our study, restoration of DIO1 expression resulted in moderate induction of enzymes involved in key pathways that undergo metabolic reprogramming in ccRCC tumors such as transketolase (TKT), nicotinamide phosphoribosyltransferase (NAMPT), and mitochondrial isoform of isocitrate dehydrogenase (IDH2).</s><s>In ccRCC cells, NAMPT inhibition attenuates their growth <ref type="bibr" target="#b44">[45]</ref>.</s><s>Strikingly, and counterintuitively to the anti-tumor activity of DIO1 <ref type="bibr" target="#b20">[21]</ref>, restoration of DIO1 expression resulted in moderate increase of TKT, NAMPT and IDH2 protein levels (Table <ref type="table" target="#tab_0">1</ref>).</s><s>DIO1 affected also expression of protein involved in amino acid metabolism (LAT1/SLC7A5 and its binding partner, CD98/4F2hc/SLC3A2), NADH   20-hydroxyeicosatetraenoic acid (20-HETE) which stimulates proliferation of ccRCC cells <ref type="bibr" target="#b45">[46]</ref>.</s><s>Increased expression of proteins involved in sex steroid inactivation (AKR1C1, AKR1C2, AKR1C3, AKR1B10) in DIO1 re-expressing renal cancer cells might indicate decreased local production of androgens, which have been linked to proliferation of renal and other cancers expressing androgen receptor.</s><s>In particular, it was recently revealed that intracrine biosynthesis of androgen contributes to tumor growth of renal cell carcinoma <ref type="bibr" target="#b46">[47]</ref>.</s><s>Due to the low cellular concentration of nuclear hormone receptors these might escape our proteome analysis missing low abundance receptor proteins compared to classical metabolic enzymes and structural proteins.</s></p><p><s>Increased levels of TKT, NAMPT, IDH2, LAT1, NDUFA3, and CYP4F11 proteins indicate that restored DIO1 expression further boosts pro-tumorous metabolic changes in ccRCC cells.</s><s>It is known that such reprogramming of cancer metabolism is tightly associated with intensified production of reactive oxygen species (ROS) <ref type="bibr" target="#b47">[48]</ref>.</s><s>For instance, it was shown that 20-HETE stimulates formation of superoxide which induces proangiogenic signaling in endothelial cells <ref type="bibr" target="#b48">[49]</ref>.</s><s>Polyunsaturated lipids that are important elements of lipoproteins and cellular membranes are particularly vulnerable targets of ROS <ref type="bibr" target="#b49">[50]</ref>.</s><s>The breakdown of lipid peroxides yields reactive bifunctional electrophiles such as 4-hydroxy-2-nonenal (4-HNE) that can further damage amino acids and DNA.</s><s>Remarkably, in cells with restored DIO1 expression we observed robust induction of aldo-keto reductases (AKR1C2, AKR1B10, AKR1C1, and AKR1C3) that protect cells against toxic effects of 4-HNE <ref type="bibr" target="#b49">[50]</ref>.</s><s>The AKRs are known biomarkers of activity of Nrf2, a basic leucine zipper (bZIP) transcription factor that controls the expression of genes involved in response to oxidative stress <ref type="bibr" target="#b50">[51]</ref>.</s><s>Our further analysis revealed that a significant proportion of proteins affected by DIO1 expression was previously reported as regulated by Nrf2 (see: S4 Table and references thereof).</s><s>They include GCLC that plays an essential role in synthesis of glutathione, an important antioxidant in ccRCC cells <ref type="bibr" target="#b6">[7]</ref> or UGT1A6 that eliminates the products of oxidative metabolism via glucuronidation <ref type="bibr" target="#b51">[52]</ref>.</s><s>These results suggest that restoration of DIO1 expression in ccRCC cells may possibly result in ROS generation that in turn triggers compensatory mechanisms that protect against oxidative stress.</s><s>While moderate ROS production can stimulate proliferation, their excess leads to oxidative damage of DNA, proteins and lipids.</s><s>To avoid cell death induced by oxidative stress, cancer cells need to carefully maintain the balance between ROS generation and scavenging <ref type="bibr" target="#b47">[48]</ref>.</s><s>Strikingly, induced DIO1 expression resulted also in initiation of mechanisms that can mitigate the ROS scavenging activity.</s><s>Mitochondrial glutamate dehydrogenase GLUD1 controls redox homeostasis in cancer cells via the product of its activity, α-ketoglutarate, and its metabolite, fumarate <ref type="bibr" target="#b52">[53]</ref>.</s><s>The latter binds to the key ROS-scavenging enzyme, glutathione peroxidase (GPx), leading to its activation, thereby providing highly efficient protection against oxidative stress.</s><s>Suppression of GLUD1 activity leads to decreased fumarate levels and GPx activity, elevation of ROS and attenuation of cancer cell proliferation and tumor growth <ref type="bibr" target="#b52">[53]</ref>.</s><s>In our study, DIO1 expression downregulated GLUD1 with concomitant increase of levels of fumarylacetoacetase (FAH) which catalyzes hydrolysis of fumarylacetoacetate to fumarate and acetate.</s><s>This data suggests that while on one hand DIO1 expression results in induction of proteins involved in antioxidative protection, on the other hand it can also potentially attenuate the activity of the key ROS-scavanger, GPx.</s></p><p><s>The fact that restoration of DIO1 expression in ccRCC cells leads to attenuation of proliferation and migration <ref type="bibr" target="#b20">[21]</ref> indicates that anti-oxidative response observed in this study could be inefficient and that oxidative stress generated by DIO1-induced acceleration of pro-tumorous metabolism could exceed antioxidative capacities of ccRCC cells, initiating mechanisms leading to cell death.</s><s>Indeed, we observed profound reduction of NMT2, a negative regulator of apoptotic responses.</s><s>NMT2 catalyzes N-myristoylation of multiple proteins and its depletion in cancer cells results in dramatic increase of apoptosis <ref type="bibr" target="#b53">[54]</ref>.</s><s>Furthermore, DIO1 induced the expression of PPIF (cyclophilin D), one of the proteins of the mitochondrial permeability transition pore.</s><s>In RCC tumors, the expression of PPIF is reduced while its induction results in apoptosis and necrosis <ref type="bibr" target="#b54">[55]</ref>.</s></p><p><s>DIO1 strongly repressed the expression of proteins involved in ccRCC progression such as aminopeptidase N (ANPEP), CYR61, and TGM2.</s><s>In renal tumors, enhanced ANPEP expression correlates with poor survival of patients <ref type="bibr" target="#b55">[56]</ref>, while high CYR61 levels stimulate proangiogenic activity of cancer cells <ref type="bibr" target="#b56">[57]</ref>.</s><s>Increased expression of TGM2 (transglutaminase-2) in ccRCC tumors contributes to cancerous proliferation, migration and invasion <ref type="bibr" target="#b57">[58]</ref> and enables survival of RCC cells by a mechanism involving autophagy-dependent p53 degradation <ref type="bibr" target="#b58">[59]</ref>.</s><s>Inhibition of TGM2 activity attenuates growth of RCC xenografts in mice <ref type="bibr" target="#b59">[60]</ref>.</s><s>In our study, DIO1 expression led to a substantial downregulation of TGM2 as well as TBC1D2 and NMI, two other regulators of autophagy.</s><s>These results raise an interesting hypothesis that DIO1 expression may interfere with autophagy mechanisms by local provision of T3 known to be involved in regulation of autophagy either directly or via acting as ligand for the T3 receptor <ref type="bibr" target="#b60">[61,</ref><ref type="bibr" target="#b61">62]</ref>.</s><s>In accordance with our recent study <ref type="bibr" target="#b20">[21]</ref>, DIO1 expression resulted also in suppression of TGFBI, and several other proteins (e.g.</s><s>PODXL, CD74) that promote RCC progression <ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b64">[65]</ref> or act as oncogenic proteins in other cancers (e.g.</s><s>FMNL2 <ref type="bibr" target="#b65">[66]</ref>, APBB1IP <ref type="bibr" target="#b66">[67]</ref>, ASAP1 <ref type="bibr" target="#b67">[68,</ref><ref type="bibr" target="#b68">69]</ref>, and LRRFIP1 <ref type="bibr" target="#b69">[70,</ref><ref type="bibr" target="#b70">71]</ref>).</s><s>Thus, it may be concluded that DIO1 re-expression in ccRCC cells results in global downregulation of proteins that directly promote cancerous proliferation, migration and invasion.</s><s>Additional information on protein of which expression was affected by DIO1 is given in Supplementary S1 File.</s></p><p><s>Regarding the mechanisms that mediate DIO1 effects in RCC cells, several scenarios can be considered.</s><s>The genes encoding proteins affected by DIO1 expression may be regulated by the product of DIO1 activity, T3.</s><s>Indeed, we observed a pronounced induction of the SLC7A5, a T3 early-response gene <ref type="bibr" target="#b71">[72]</ref>.</s><s>Remarkably, together with SLC3A2, SLC7A5 forms an efficient transporter facilitating intracellular trafficking of thyroid hormones <ref type="bibr" target="#b44">[45]</ref>.</s><s>In agreement with induced expression of SLC7A5 and SLC3A2, we observed substantial increase in intracellular T4 concentrations.</s><s>Unfortunately, we could not detect T3 in these cells but our recent study suggested that DIO1 ectopically expressed in renal cancer cells deiodinates T4 to produce T3 that induces changes in expression of target genes <ref type="bibr" target="#b20">[21]</ref>.</s><s>Specifically, we showed that that supplementation of KIJ265T and KIJ308T cells (not transfected with DIO1-expressing plasmids) with T3 did not recapitulate the effects of ectopic DIO1 expression, suggesting inefficient intracellular transport of T3.</s><s>These results were in accordance with data showing decreased expression of T3 transporters (including SLC3A2) in renal tumors.</s><s>In contrast, supplementation of KIJ265T-DIO1(+) cells with DIO1 substrate, T4, resulted in changed expression of DIO1-affected genes in a dose dependent manner.</s><s>Remarkably, no effects of T4 supplementation were observed in RCC cells devoid of ectopic DIO1 expression.</s><s>These results indicated that ectopic DIO1 expression enabled conversion of T4 to T3 which could further affect the expression of target genes <ref type="bibr" target="#b20">[21]</ref>.</s><s>DIO1 may also affect gene expression by indirect T3 actions.</s><s>Thyroid hormone is a powerful inducer of oxidative stress <ref type="bibr" target="#b61">[62]</ref>, stimulates rapid translocation of Nrf2 from cytosol to nucleus <ref type="bibr" target="#b72">[73]</ref>, and activates the expression of Nrf2 targets, AKR1C1-C3 <ref type="bibr" target="#b73">[74]</ref> and TKT <ref type="bibr" target="#b74">[75]</ref>.</s><s>Thus, the robust DIO1-induced upregulation of genes which are known Nrf2 targets (S5 Table and references thereof) may possible be explained by T3-mediated regulation of Nrf2.</s><s>Furthermore, apart from iodothyronines, the product of DIO1 activity is the iodide.</s><s>Treatment of breast cancer cells with iodine/iodide results in upregulation of ACR1C1 and SLC7A5 <ref type="bibr" target="#b75">[76]</ref>, the two genes that were upregulated by DIO1 overexpression in our study.</s></p><p><s>In general, the results of our study are in agreement with the known effects of deiodinases in cancer and healthy cells.</s><s>The changes in expression of iodothyronine deiodinases provide Simultaneously, restoration of DIO1 in ccRCC cells leads to enhanced expression of proteins that contribute to metabolic reprogramming of renal tumors and affect PPP, TCA cycle, metabolism of amino acids and lipids.</s><s>This may be associated with prominent induction of ROS that in turn trigger antioxidative response and results in enhanced levels of proteins of Nrf2 pathway (right side of the drawing).</s><s>On the other hand, induced DIO1 expression can also possibly result in attenuation of ROS-scavenging system by decreasing GLUD1 and inducing FAH (middle part of the drawing).</s><s>Altogether, this may possibly result in ROS levels that exceed the compensatory buffering systems of ccRCC cells and trigger mechanisms leading to apoptosis or autophagy.</s><s>https://doi.org/10.1371/journal.pone.0190179.g010</s><s>tight spatio-temporal control of cellular T3 levels that initiate signaling essential for proliferation and differentiation.</s><s>Upregulation of type 3 deiodinase (DIO3), a T3 inactivating enzyme, is required during initial, proliferative phase of myogenesis.</s><s>In contrast, expression of DIO2 at late phase of myogenesis enables T3-mediated signaling that stimulate cell differentiation <ref type="bibr" target="#b76">[77]</ref>.</s><s>Similarly, in proliferating colorectal cancer stem cells (CR-CSCs), the expression of DIO2 is attenuated, while its expression rapidly increases during cell differentiation.</s><s>In contrast, DIO3 expression is oppositely regulated during CR-CSCs' differentiation <ref type="bibr" target="#b77">[78]</ref>.</s><s>Most of described so far T3 effects on cellular proliferation and differentiation are mediated by its specific nuclear receptors (TRs) <ref type="bibr" target="#b11">[12]</ref>.</s><s>In our proteomic analysis, we could not detect TRs, as well as DIO2 and DIO3 which can result from low abundance of these proteins in renal cancer <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b78">79]</ref>.</s><s>Since genes encoding TRs are T3-regulated, it can be expected that their expression could be enhanced by DIO1 re-expression.</s><s>Remarkably, thyroid hormones can also influence cell functioning by various non-genomic mechanisms that do not necessarily involve TRs <ref type="bibr" target="#b79">[80]</ref>, providing another possible explanation for deiodinase effects in cancer cells.</s><s>We found that DIO1-induced expression changes detected by proteomic and qPCR analysis were highly consistent.</s><s>The mRNA expression changes of all ten validated genes were in accordance with the results of proteomic analysis.</s><s>This may possibly suggest that DIO1 re-expression may result in initiation of transcriptional reprograming.</s><s>Interestingly, DIO1 expression resulted in decreased levels of transcriptional regulators, STAT3 and WIZ.</s><s>STAT3 is a well-known regulator of multiple genes involved in apoptosis, proliferation, migration and invasion <ref type="bibr" target="#b80">[81]</ref>.</s><s>Its persistent activation in cancers, including ccRCC, directly contributes to tumor development and progression <ref type="bibr" target="#b80">[81,</ref><ref type="bibr" target="#b81">82]</ref>.</s><s>Inhibition of STAT3 pathway in ccRCC induces apoptosis, attenuates angiogenesis and metastasis in renal cancer mouse models <ref type="bibr" target="#b82">[83,</ref><ref type="bibr" target="#b83">84]</ref>.</s><s>DIO1 effects could be also mediated by WIZ, a transcriptional co-regulator, involved in chromatin regulation <ref type="bibr" target="#b84">[85]</ref> or EIF4A2, an important regulator of translation <ref type="bibr" target="#b85">[86]</ref>.</s><s>Future studies are needed to reveal the detailed mechanism of DIO1-induced changes in proteome of renal cancer cells.</s></p><p><s>While interpreting the results of our study, it should be also considered that DIO1-induced proteome changes were analyzed in a ccRCC-derived cell line.</s><s>In contrast, tumors are a mixture of different types of cells, including these of epithelial, endothelial or stromal origin.</s><s>The remarkable correlations between the expression of DIO1 transcript and some of DIO1-affected genes in tissue samples derived from ccRCC patients may possibly suggest that loss of DIO1 expression in ccRCC tumors may influence the pattern of gene expression in vivo.</s><s>It would be interesting to see if changes in DIO1 expression may affect other cells and processes that contribute to tumor formation, in particular angiogenesis or infiltrating cells of immune system.</s><s>These aspects of DIO1 activity in cancer cells should be investigated in the future.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>In summary, the results of this and our previous <ref type="bibr" target="#b20">[21]</ref> study suggest that restoration of DIO1 expression affects functioning of cancer cells in two modes ( <ref type="bibr">Fig 10)</ref>.</s><s>On one hand, it further boosts protumorous changes in ccRCC metabolism, by changing the levels of proteins involved in PPP, TCA cycle or metabolism of lipids, steroids and amino acids.</s><s>This in turn may possibly result in massive generation of ROS that initiate robust induction of proteins involved in antioxidative response.</s><s>If ROS generation exceeds the buffering capacities of antioxidative system, this may initiate apoptotic responses.</s><s>On the other hand, increased DIO1 and resulting local T3 production activity may globally downregulate oncogenic proteins that promote cancerous proliferation, migration and invasion of ccRCC cells.</s><s>Altogether, these changes result in suppression of cancerous phenotype of ccRCC cells with restored DIO1 expression.</s><s>At the same time, the results of our study may possibly suggest that loss of DIO1</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>(threshold: 1 . 3 -</head><label>13</label><figDesc><div><p><s>fold change, FDR&lt;0.05,</s><s>p&lt;0.05).</s><s>The raw proteomic data are given in S2 Table.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>https://doi.org/10.1371/journal.pone.0190179.t002</s><s>expressions of AKR1C1, AKR1C2, SLC3A2, and SLC7A5 were increased in KIJ265T-DIO1(+) cells when compared with control cells (p&lt;0.05) while expressions of NMI, PLAU, S100A2, TBC1D2, TGM2 and WIZ were decreased in KIJ265T-DIO1(+) cells when compared with control cells (p&lt;0.05) (Fig5).</s><s>Furthermore, for the vast majority of analyzed genes (except for SLC3A2, SLC7A5, and TBC1D2) similar trend was observed when gene expression was validated in independent RCC-derived cell line, KIJ308T, with or without ectopic expression of DIO1 (S1 and S2 Figs).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Functional annotation of proteins that were differently expressed in DIO1(+) cells when compared with DIO1(-) cells.</s><s>The pie charts show results of analysis performed using PANTHER (http:// pantherdb.org).</s><s>The largest categories of biological processes, molecular function, and cellular components related to the identified proteins are shown with arrows.</s><s>https://doi.org/10.1371/journal.pone.0190179.g001</s></p></div></figDesc><graphic coords="8,200.01,78.01,251.94,329.67" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 2 .Fig 3 .</head><label>23</label><figDesc><div><p><s>Fig 2. Metabolic processes related to proteins affected by DIO1 expression in ccRCC cells.</s><s>Analysis was performed using PANTHER (www.pantherdb.org).</s><s>https://doi.org/10.1371/journal.pone.0190179.g002</s></p></div></figDesc><graphic coords="9,200.01,78.01,248.09,288.17" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. The network of proteins affected by DIO1 expression.</s><s>A. Network of expression correlations; the proteomic data of protein expression levels were analyzed using Metscape/Cytoscape application.</s><s>Blue lines: negative correlations, red lines: positive correlations.</s><s>Thickness of lines indicates strength of correlations.</s><s>B. Protein interaction network generated with STRING v. 10.5 accessed on 2017.11.06.</s><s>with default settings (minimum required interaction score: medium confidence 0.4).</s><s>Three major clusters are labelled as I (cytoskeleton remodeling and intracellular trafficking), II (cellular adhesion), and III (metabolism).</s><s>https://doi.org/10.1371/journal.pone.0190179.g004</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig 5 .</head><label>5</label><figDesc><div><p><s>Fig 5. Validation of proteomic data using qPCR.</s><s>The plots show mean ± SEM results of three independent biological experiments performed on KIJ265T-DIO1(+) cells when compared with KIJ265-DIO1(-) cells.</s><s>Statistical analysis was performed using t-test.</s><s>*p&lt;0.05,</s><s>**p&lt;0.01.</s><s>https://doi.org/10.1371/journal.pone.0190179.g005</s></p></div></figDesc><graphic coords="13,200.01,78.01,251.94,545.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig 6 .</head><label>6</label><figDesc><div><p><s>Fig 6.</s><s>The transcript expression of genes affected by DIO1 restoration is disturbed in renal cancer.</s><s>The plots show results of qPCR analysis performed in 30 matched pairs of tumor (TUMOR) and control (CONTROL) tissue samples.</s><s>Statistical analysis was performed using Wilcoxon matched pairs signed test.</s><s>* p&lt;0.05; **p&lt;0.01;</s><s>**** p&lt;0.0001.</s><s>https://doi.org/10.1371/journal.pone.0190179.g006</s></p></div></figDesc><graphic coords="14,200.01,78.01,251.94,541.81" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig 7 .</head><label>7</label><figDesc><div><p><s>Fig 7. Matrix of correlations between the transcript expression of DIO1 and DIO1-affected genes in renal tumors.</s><s>The upper table shows Spearman's rank correlation coefficient values for gene expressions analyzed in 30 RCC tumors and 30 paired-matched controls.</s><s>Dark red: r s !0.85, red: 0.85&gt;r s !0.7, orange: 0.7&gt;r s !0.3, green r s &lt;-0.3.</s><s>The lower table shows p values (yellow: p&lt;0.05).</s><s>https://doi.org/10.1371/journal.pone.0190179.g007</s></p></div></figDesc><graphic coords="15,180.00,78.01,395.94,299.45" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig 8 .Fig 9 .</head><label>89</label><figDesc><div><p><s>Fig 8. Altered transcript expression of DIO1-affected genes correlates with poor survival of renal cancer patients.</s><s>Kaplan-Meyer analysis for DIO1-affected genes identified in the study.</s><s>The analysis was performed on independent cohort of 468 patients with ccRCC, basing on transcriptomic data published by The Cancer Genome Atlas Network Consortium.</s><s>The red and green lines depict patients with high and low risk of death, respectively.</s><s>The numbers of patients in each group are shown below graphs.</s><s>Censored observations are shown with +.</s><s>Log-rank p values, hazard ratio (HR) and confidence intervals (CI) are shown above each graph.</s><s>Expression of genes in each risk group is given in S4 Fig. https://doi.org/10.1371/journal.pone.0190179.g008</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig 10 .</head><label>10</label><figDesc><div><p><s>Fig 10.</s><s>The model depicting the proteomic effects of DIO1 restoration in renal cancer.</s><s>Changes in protein levels are illustrated with green (decreased level) and red (increased level) colors.</s><s>Induction of DIO1 expression in renal cancer cells results in robust downregulation of oncoproteins that are well known inhibitors of apoptosis and promoters of ccRCC proliferation, migration and invasion (left side of the drawing).Simultaneously, restoration of DIO1 in ccRCC cells leads to enhanced expression of proteins that contribute to metabolic reprogramming of renal tumors and affect PPP, TCA cycle, metabolism of amino acids and lipids.</s><s>This may be associated with prominent induction of ROS that in turn trigger antioxidative response and results in enhanced levels of proteins of Nrf2 pathway (right side of the drawing).</s><s>On the other hand, induced DIO1 expression can also possibly result in attenuation of ROS-scavenging system by decreasing GLUD1 and inducing FAH (middle part of the drawing).</s><s>Altogether, this may possibly result in ROS levels that exceed the compensatory buffering systems of ccRCC cells and trigger mechanisms leading to apoptosis or autophagy.</s></p></div></figDesc><graphic coords="19,200.01,78.01,255.06,378.65" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="16,200.01,78.01,289.59,623.68" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . The proteins upregulated in human renal cancer cell with induced DIO1 expression. Gene name Protein name Fold change (DIO1+/DIO1-ratio) P value</head><label>1</label><figDesc></figDesc><table><row><cell>AKR1C2</cell><cell>Aldo-keto reductase family 1 member C2</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table .</head><label>.</label><figDesc></figDesc><table /><note><p><s>https://doi.org/10.1371/journal.pone.0190179.t001</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 . The proteins downregulated in human renal cancer cell with induced DIO1 expression.</head><label>2</label><figDesc></figDesc><table><row><cell>Gene name</cell><cell>Protein name</cell><cell>Fold change</cell><cell>P value</cell></row><row><cell></cell><cell></cell><cell>(DIO1+/DIO1-)</cell><cell></cell></row><row><cell></cell><cell></cell><cell>ratio)</cell><cell></cell></row><row><cell>AFAP1L2</cell><cell>Actin filament-associated protein 1-like 2</cell><cell>-31.22</cell><cell>1.73×10 -5</cell></row><row><cell>ANPEP</cell><cell>Aminopeptidase N</cell><cell>-8.74</cell><cell>3.47×10 -6</cell></row><row><cell>CYR61</cell><cell>Protein CYR61</cell><cell>-8.25</cell><cell>2.47×10 -7</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Continued)</s></p></div></figDesc><table><row><cell>Gene name</cell><cell>Protein name</cell><cell>Fold change</cell><cell>P value</cell></row><row><cell></cell><cell></cell><cell>(DIO1+/DIO1-)</cell><cell></cell></row><row><cell></cell><cell></cell><cell>ratio)</cell><cell></cell></row><row><cell>DPP9</cell><cell>Dipeptidyl peptidase 9</cell><cell>-1.81</cell><cell>4.50×10 -4</cell></row><row><cell>IMMT</cell><cell>MICOS complex subunit MIC60</cell><cell>-1.73</cell><cell>1.72×10 -4</cell></row><row><cell>NF2</cell><cell>Merlin</cell><cell>-1.70</cell><cell>4.17×10 -4</cell></row><row><cell>STXBP2</cell><cell>Syntaxin-binding protein 2</cell><cell>-1.66</cell><cell>9.78×10 -5</cell></row><row><cell>NCEH1</cell><cell>Neutral cholesterol ester hydrolase 1</cell><cell>-1.64</cell><cell>8.42×10 -4</cell></row><row><cell>S100A11</cell><cell>Protein S100-A11;Protein S100-A11, N-terminally processed</cell><cell>-1.61</cell><cell>1.19×10 -3</cell></row><row><cell>ENAH</cell><cell>Protein enabled homolog</cell><cell>-1.61</cell><cell>3.05×10 -4</cell></row><row><cell>YWHAH</cell><cell>14-3-3 protein eta</cell><cell>-1.60</cell><cell>5.87×10 -4</cell></row><row><cell>RIPK1</cell><cell>Receptor-interacting serine/threonine-protein kinase 1</cell><cell>-1.59</cell><cell>1.51×10 -4</cell></row><row><cell>GLUD1;</cell><cell>Glutamate dehydrogenase 1, mitochondrial; Glutamate dehydrogenase 2, mitochondrial</cell><cell>-1.56</cell><cell>1.40×10 -3</cell></row><row><cell>GLUD2</cell><cell></cell><cell></cell><cell></cell></row><row><cell>AP2B1</cell><cell>AP-2 complex subunit beta</cell><cell>-1.55</cell><cell>1.80×10 -4</cell></row><row><cell>DFNA5</cell><cell>Non-syndromic hearing impairment protein 5</cell><cell>-1.53</cell><cell>1.09×10 -3</cell></row><row><cell>STAT3</cell><cell>Signal transducer and activator of transcription 3; Signal transducer and activator of transcription</cell><cell>-1.52</cell><cell>2.30×10 -4</cell></row><row><cell>PLS3</cell><cell>Plastin-3</cell><cell>-1.51</cell><cell>7.19×10 -6</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | https://doi.org/10.1371/journal.pone.0190179December 22, 2017  </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors thank Theo J. Visser for anti-DIO1 serum and pcDNA3-DIO1 plasmid.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>expression in ccRCC tumors could be an adaptive mechanism, protecting the cells against overstimulation of cancer metabolism and induction of autophagy and or apoptosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S1 Table. Primers and probes used for qPCR. (DOC)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S2 Table. Raw data of proteomic analysis. (XLSX)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S3 Table. Results of enrichment analysis performed using http://geneontology.org/ platform and PANTHER Overrepresentation Test (release 20160715). (XLSX)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S4 Table. Matrix of correlations between the expressions of proteins affected by DIO1 expression in renal cancer cells. The analysis was performed using</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">EAU guidelines on renal cell carcinoma: 2014 update</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ljungberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bensalah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Canfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dabestani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hora</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2015.01.005</idno>
		<idno type="PMID">25616710</idno>
		<ptr target="https://doi.org/10.1016/j.eururo.2015.01.005" />
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="913" to="924" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">VHL and HIF signalling in renal cell carcinogenesis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Baldewijns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Van Vlodrop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Vermeulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Soetekouw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Engeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>De Bruïne</surname></persName>
		</author>
		<idno type="DOI">10.1002/path.2689</idno>
		<idno type="PMID">20225241</idno>
		<ptr target="https://doi.org/10.1002/path.2689" />
	</analytic>
	<monogr>
		<title level="j">J Pathol</title>
		<imprint>
			<biblScope unit="volume">221</biblScope>
			<biblScope unit="page" from="125" to="138" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">I</forename><surname>Wettersten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Hakimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Johnstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Donohoe</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-14-1703</idno>
		<idno type="PMID">25952651</idno>
		<ptr target="https://doi.org/10.1158/0008-5472.CAN-14-1703" />
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="2541" to="2552" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Comprehensive molecular characterization of clear cell renal cell carcinoma</title>
		<idno type="DOI">10.1038/nature12222</idno>
		<idno type="PMID">23792563</idno>
		<ptr target="https://doi.org/10.1038/nature12222" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">499</biblScope>
			<biblScope unit="page" from="43" to="49" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Cancer Genome Atlas Research Network</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients</title>
		<author>
			<persName><forename type="first">P</forename><surname>Popławski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tohge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bogusławska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rybicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tański</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Treviño</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbadis.2016.12.011</idno>
		<idno type="PMID">28012969</idno>
		<ptr target="https://doi.org/10.1016/j.bbadis.2016.12.011" />
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1863</biblScope>
			<biblScope unit="page" from="744" to="752" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The genetic basis of kidney cancer: a metabolic disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Linehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Srinivasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Schmidt</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrurol.2010.47</idno>
		<idno type="PMID">20448661</idno>
		<ptr target="https://doi.org/10.1038/nrurol.2010.47" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Urol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="277" to="285" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gatto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nookaew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nielsen</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1319196111</idno>
		<idno type="PMID">24550497</idno>
		<ptr target="https://doi.org/10.1073/pnas.1319196111" />
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="E866" to="E875" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Hakimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Reznik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Creighton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brannon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Luna</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ccell.2015.12.004</idno>
		<idno type="PMID">26766592</idno>
		<ptr target="https://doi.org/10.1016/j.ccell.2015.12.004" />
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="104" to="116" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The classic pathways of thyroid hormone metabolism</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Van Der Spek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fliers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boelen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2017.01.025</idno>
		<idno type="PMID">28109953</idno>
		<ptr target="https://doi.org/10.1016/j.mce.2017.01.025" />
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Metabolism of Thyroid Hormone</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Peeters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chrousos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dungan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Feingold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grossman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hershman</surname></persName>
		</author>
		<ptr target="https://www.ncbi.nlm.nih.gov/books/NBK285545/" />
	</analytic>
	<monogr>
		<title level="j">De Groot LJ</title>
		<imprint>
			<date type="published" when="2000">2000-2017</date>
			<publisher>MDText.com, Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Maia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Goemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Wajner</surname></persName>
		</author>
		<idno type="DOI">10.1530/JOE-10-0481</idno>
		<idno type="PMID">21415143</idno>
		<ptr target="https://doi.org/10.1530/JOE-10-0481" />
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">209</biblScope>
			<biblScope unit="page" from="283" to="297" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Thyroid hormone receptors, cell growth and differentiation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pascual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aranda</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbagen.2012.03.012</idno>
		<idno type="PMID">22484490</idno>
		<ptr target="https://doi.org/10.1016/j.bbagen.2012.03.012" />
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1830</biblScope>
			<biblScope unit="page" from="3908" to="3916" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Moeller</surname></persName>
		</author>
		<author>
			<persName><surname>Fu</surname></persName>
		</author>
		<idno type="DOI">10.1530/ERC-12-0219</idno>
		<idno type="PMID">23319493</idno>
		<ptr target="https://doi.org/10.1530/ERC-12-0219" />
	</analytic>
	<monogr>
		<title level="j">Endocr Relat Cancer</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="R19" to="29" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Sonic hedgehoginduced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dentice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Luongo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ambrosio</forename><forename type="middle">R</forename><surname>Elefante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mirebeau-Prunier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0706754104</idno>
		<idno type="PMID">17720805</idno>
		<ptr target="https://doi.org/10.1073/pnas.0706754104" />
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="14466" to="14471" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dentice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Luongo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ambrosio</forename><forename type="middle">R</forename><surname>Sibilio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iaccarino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2012.06.042</idno>
		<idno type="PMID">22771508</idno>
		<ptr target="https://doi.org/10.1053/j.gastro.2012.06.042" />
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1037" to="1047" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">The sonic hedgehog-induced type 3 deiodinase facilitates tumorigenesis of basal cell carcinoma by reducing Gli2 inactivation. Endocrinology</title>
		<author>
			<persName><forename type="first">C</forename><surname>Luongo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ambrosio</forename><forename type="middle">R</forename><surname>Salzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dlugosz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Missero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dentice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1210/en.2013-2108</idno>
		<idno type="PMID">24693967</idno>
		<ptr target="https://doi.org/10.1210/en.2013-2108" />
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="2077" to="2088" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma Cells</title>
		<author>
			<persName><forename type="first">C</forename><surname>Miro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ambrosio</forename><forename type="middle">R</forename></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Stefano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Girolamo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Cicco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cicatiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename></persName>
		</author>
		<idno type="DOI">10.1089/thy.2016.0532</idno>
		<idno type="PMID">28088877</idno>
		<ptr target="https://doi.org/10.1089/thy.2016.0532" />
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="567" to="576" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Thyroid hormone promotes differentiation of colon cancer stem cells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Cicatiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ambrosio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dentice</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2017.03.017</idno>
		<idno type="PMID">28342853</idno>
		<ptr target="https://doi.org/10.1016/j.mce.2017.03.017" />
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Type I 5&apos;-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Pachucki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ambroziak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nauman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nauman</surname></persName>
		</author>
		<idno type="DOI">10.1007/BF03343855</idno>
		<idno type="PMID">11383912</idno>
		<ptr target="https://doi.org/10.1007/BF03343855" />
	</analytic>
	<monogr>
		<title level="j">J Endocrinol Invest</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="253" to="261" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Master</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wo ´jcicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Piekiełko-Witkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bogusławska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Popławski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tański</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbadis.2010.07.025</idno>
		<idno type="PMID">20691260</idno>
		<ptr target="https://doi.org/10.1016/j.bbadis.2010.07.025" />
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1802</biblScope>
			<biblScope unit="page" from="995" to="1005" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Induction of type 1 iodothyronine deiodinase expression inhibits proliferation and migration of renal cancer cells</title>
		<author>
			<persName><forename type="first">P</forename><surname>Poplawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rybicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boguslawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rodzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nauman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2016.12.004</idno>
		<idno type="PMID">27940296</idno>
		<ptr target="https://doi.org/10.1016/j.mce.2016.12.004" />
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">442</biblScope>
			<biblScope unit="page" from="58" to="67" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Regulation of type 1 iodothyronine deiodinase by LXRα</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sakane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kanamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Yamauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tagami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miura</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0179213</idno>
		<idno type="PMID">28617824</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0179213" />
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">e0179213</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Forkhead box A1 (FOXA1) and A2 (FOXA2) oppositely regulate human type 1 iodothyronine deiodinase gene in liver</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kanamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tagami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ueda-Sakane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yasoda</surname></persName>
		</author>
		<idno type="DOI">10.1210/en.2011-1310</idno>
		<idno type="PMID">22067325</idno>
		<ptr target="https://doi.org/10.1210/en.2011-1310" />
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="492" to="500" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">MiR-224 targets the 3&apos;UTR of type 1 5&apos;-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Boguslawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wojcicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Piekielko-Witkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Master</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nauman</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0024541</idno>
		<idno type="PMID">21912701</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0024541" />
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e24541</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Pathway signature and cellular differentiation in clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Tun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Marlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Von Roemeling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kreinest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0010696</idno>
		<idno type="PMID">20502531</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0010696" />
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e10696</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Regulatory feedback loop between T3 and microRNAs in renal cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Boguslawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Piekielko-Witkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wojcicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kedzierska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Poplawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nauman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2014.01.006</idno>
		<idno type="PMID">24440748</idno>
		<ptr target="https://doi.org/10.1016/j.mce.2014.01.006" />
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">384</biblScope>
			<biblScope unit="page" from="61" to="70" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The effect of genetic variation in the type 1 deiodinase gene on the interindividual variation in serum thyroid hormone levels: an investigation in healthy Danish twins</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Van Der Deure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Peeters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Uitterlinden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fenger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">O</forename><surname>Kyvik</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2265.2008.03420.x</idno>
		<idno type="PMID">18793344</idno>
		<ptr target="https://doi.org/10.1111/j.1365-2265.2008.03420.x" />
	</analytic>
	<monogr>
		<title level="j">Clin Endocrinol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="954" to="960" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Effects of thyroid hormone on growth and differentiation of L6 muscle cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Zuidwijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Van Hardeveld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BAM</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="59" to="68" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Metabolic effect of 3,3&apos;,5&apos;-triiodothyronine in cultured growth hormone-producing rat pituitary tumor cells. Evidence for a unique mechanism of thyroid hormone action</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>St Germain</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI112049</idno>
		<idno type="PMID">4031075</idno>
		<ptr target="https://doi.org/10.1172/JCI112049" />
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="890" to="893" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Regulation of the active transport of 3,3&apos;,5-triiodothyronine (T3) into primary cultured rat hepatocytes by ATP</title>
		<author>
			<persName><forename type="first">E</forename><surname>Krenning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Docter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bernard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hennemann</surname></persName>
		</author>
		<idno type="PMID">7428942</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="279" to="282" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Quantitative Analysis of Thyroid Hormone Metabolites in Cell Culture Samples Using LC-MS/MS</title>
		<author>
			<persName><forename type="first">D</forename><surname>Rathmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rijntjes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lietzow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ko ¨hrle</surname></persName>
		</author>
		<idno type="DOI">10.1159/000430840</idno>
		<idno type="PMID">26601073</idno>
		<ptr target="https://doi.org/10.1159/000430840" />
	</analytic>
	<monogr>
		<title level="j">Eur Thyroid J</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="51" to="58" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">A validated LC-MS/MS method for cellular thyroid hormone metabolism: uptake and turnover of mono-iodinated thyroid hormone metabolites by PCCL3 thyrocytes</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schanze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Monk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rijntjes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rathmann</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Josef</forename><surname>Ko ¨hrle</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0183482</idno>
		<idno type="PMID">28837607</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0183482" />
	</analytic>
	<monogr>
		<title level="j">PLOS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e0183482</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Quantitative Evaluation of Filter Aided Sample Preparation (FASP) and Multienzyme Digestion FASP Protocols</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wiśniewski</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.analchem.6b00859</idno>
		<idno type="PMID">27119963</idno>
		<ptr target="https://doi.org/10.1021/acs.analchem.6b00859" />
	</analytic>
	<monogr>
		<title level="j">Anal Chem</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="5438" to="5443" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Multi-enzyme digestion FASP and the &apos;Total Protein Approach&apos;-based absolute quantification of the Escherichia coli proteome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wiśniewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rakus</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jprot.2014.07.012</idno>
		<idno type="PMID">25063446</idno>
		<ptr target="https://doi.org/10.1016/j.jprot.2014.07.012" />
	</analytic>
	<monogr>
		<title level="j">J Proteomics</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="322" to="331" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Fast and sensitive total protein and Peptide assays for proteomic analysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wiśniewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Z</forename><surname>Gaugaz</surname></persName>
		</author>
		<idno type="DOI">10.1021/ac504689z</idno>
		<idno type="PMID">25837572</idno>
		<ptr target="https://doi.org/10.1021/ac504689z" />
	</analytic>
	<monogr>
		<title level="j">Anal Chem</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="4110" to="4116" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Label-Free and Standard-Free Absolute Quantitative Proteomics Using the &quot;Total Protein&quot; and &quot;Proteomic Ruler</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wiśniewski</surname></persName>
		</author>
		<idno type="DOI">10.1016/bs.mie.2016.10.002</idno>
		<idno type="PMID">28109442</idno>
		<ptr target="https://doi.org/10.1016/bs.mie.2016.10.002" />
	</analytic>
	<monogr>
		<title level="j">Approaches. Methods Enzymol</title>
		<imprint>
			<biblScope unit="volume">585</biblScope>
			<biblScope unit="page" from="49" to="60" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Gene Ontology Consortium: going forward</title>
		<author>
			<persName><forename type="first">Gene</forename><surname>Ontology Consortium</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gku1179</idno>
		<idno type="PMID">25428369</idno>
		<ptr target="https://doi.org/10.1093/nar/gku1179" />
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="D1049" to="D1056" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Muruganujan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kang</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gkw1138</idno>
		<idno type="PMID">27899595</idno>
		<ptr target="https://doi.org/10.1093/nar/gkw1138" />
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">D1</biblScope>
			<biblScope unit="page" from="D183" to="D189" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible</title>
		<author>
			<persName><forename type="first">D</forename><surname>Szklarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Simonovic</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gkw937</idno>
		<idno type="PMID">27924014</idno>
		<ptr target="https://doi.org/10.1093/nar/gkw937" />
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">D1</biblScope>
			<biblScope unit="page" from="D362" to="D368" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Normalization of real-time quantitative RT-PCR data: a model based variance estimation approach to identify genes suited for normalization -applied to bladder-and colon-cancer data-sets</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ledet-Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ørntoft</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-04-0496</idno>
		<idno type="PMID">15289330</idno>
		<ptr target="https://doi.org/10.1158/0008-5472.CAN-04-0496" />
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="5245" to="5250" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Expression of genes involved in cellular adhesion and extracellular matrix remodeling correlates with poor survival of patients with renal cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Boguslawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kedzierska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Poplawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rybicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Piekielko-Witkowska</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.juro.2015.11.050</idno>
		<idno type="PMID">26631499</idno>
		<ptr target="https://doi.org/10.1016/j.juro.2015.11.050" />
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="1892" to="1902" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Aguirre-Gamboa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gomez-Rueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Martı</forename><surname>´nez-Ledesma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martı ´nez-Torteya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chacolla-Huaringa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rodriguez-Barrientos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0074250</idno>
		<idno type="PMID">24066126</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0074250" />
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e74250</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tomczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Czerwińska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wiznerowicz</surname></persName>
		</author>
		<idno type="DOI">10.5114/wo.2014.47136</idno>
		<idno type="PMID">25691825</idno>
		<ptr target="https://doi.org/10.5114/wo.2014.47136" />
	</analytic>
	<monogr>
		<title level="j">Contemp Oncol (Pozn)</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="A68" to="77" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Structure and function of thyroid hormone plasma membrane transporters</title>
		<author>
			<persName><forename type="first">U</forename><surname>Schweizer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Johannes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Braun</surname></persName>
		</author>
		<idno type="DOI">10.1159/000367858</idno>
		<idno type="PMID">25538896</idno>
		<ptr target="https://doi.org/10.1159/000367858" />
	</analytic>
	<monogr>
		<title level="j">Eur Thyroid J</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="143" to="153" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth</title>
		<author>
			<persName><forename type="first">Abu</forename><surname>Aboud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Senapedis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Baloglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Argueta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename></persName>
		</author>
		<idno type="DOI">10.1158/1535-7163.MCT-16-0197</idno>
		<idno type="PMID">27390344</idno>
		<ptr target="https://doi.org/10.1158/1535-7163.MCT-16-0197" />
	</analytic>
	<monogr>
		<title level="j">Mol Cancer Ther</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="2119" to="2129" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth</title>
		<author>
			<persName><forename type="first">A</forename><surname>Alexanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Rufanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Flasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sorokin</surname></persName>
		</author>
		<idno type="PMID">19846914</idno>
	</analytic>
	<monogr>
		<title level="j">Anticancer Res</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="3819" to="3824" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Intracrine androgen biosynthesis in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Modi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Faiena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2017.42</idno>
		<idno type="PMID">28253524</idno>
		<ptr target="https://doi.org/10.1038/bjc.2017.42" />
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="937" to="943" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Nogueira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hay</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-12-1424</idno>
		<idno type="PMID">23719265</idno>
		<ptr target="https://doi.org/10.1158/1078-0432.CCR-12-1424" />
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="4309" to="4314" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Arbab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Falck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
		<idno type="DOI">10.1124/jpet.106.115360</idno>
		<idno type="PMID">17210799</idno>
		<ptr target="https://doi.org/10.1124/jpet.106.115360" />
	</analytic>
	<monogr>
		<title level="j">J Pharmacol Exp Ther</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="page" from="18" to="27" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Penning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Drury</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.abb.2007.04.024</idno>
		<idno type="PMID">17537398</idno>
		<ptr target="https://doi.org/10.1016/j.abb.2007.04.024" />
	</analytic>
	<monogr>
		<title level="j">Arch Biochem Biophys</title>
		<imprint>
			<biblScope unit="volume">464</biblScope>
			<biblScope unit="page" from="241" to="250" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Macleod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcmahon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Plummer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Penning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Igarashi</surname></persName>
		</author>
		<idno type="DOI">10.1093/carcin/bgp176</idno>
		<idno type="PMID">19608619</idno>
		<ptr target="https://doi.org/10.1093/carcin/bgp176" />
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1571" to="1580" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kalthoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Ehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Freiberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Manns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Strassburg</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M109.075770</idno>
		<idno type="PMID">20053997</idno>
		<ptr target="https://doi.org/10.1074/jbc.M109.075770" />
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="5993" to="6002" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Alesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ccell.2014.12.006</idno>
		<idno type="PMID">25670081</idno>
		<ptr target="https://doi.org/10.1016/j.ccell.2014.12.006" />
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="257" to="270" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Ducker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Upson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1158/1541-7786.MCR-05-0037</idno>
		<idno type="PMID">16123142</idno>
		<ptr target="https://doi.org/10.1158/1541-7786.MCR-05-0037" />
	</analytic>
	<monogr>
		<title level="j">Mol Cancer Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="463" to="476" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Cyclophilin D-mediated apoptosis attributes to sorafenib-induced cytotoxicity in clear cell-renal cell carcinoma</title>
		<author>
			<persName><forename type="first">W</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Q</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejphar.2014.12.025</idno>
		<idno type="PMID">25614335</idno>
		<ptr target="https://doi.org/10.1016/j.ejphar.2014.12.025" />
	</analytic>
	<monogr>
		<title level="j">Eur J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">749</biblScope>
			<biblScope unit="page" from="142" to="150" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">The impact of peptidase activity on clear cell renal cell carcinoma survival</title>
		<author>
			<persName><forename type="first">G</forename><surname>Larrinaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sanz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Unda</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajprenal.00477.2012</idno>
		<idno type="PMID">23019229</idno>
		<ptr target="https://doi.org/10.1152/ajprenal.00477" />
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="F1584" to="F1591" />
			<date type="published" when="2012">2012. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Chintalapudi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Markiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dammai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Champion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Hoda</surname></persName>
		</author>
		<idno type="DOI">10.1093/carcin/bgn019</idno>
		<idno type="PMID">18212329</idno>
		<ptr target="https://doi.org/10.1093/carcin/bgn019" />
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="696" to="703" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hidaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Seki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nohata</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.417</idno>
		<idno type="PMID">22294552</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.417" />
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="44" to="57" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1038/cddis.2016.14</idno>
		<idno type="PMID">27031960</idno>
		<ptr target="https://doi.org/10.1038/cddis.2016.14" />
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e2163</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Ku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">B</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00432-014-1623-5</idno>
		<idno type="PMID">24610445</idno>
		<ptr target="https://doi.org/10.1007/s00432-014-1623-5" />
	</analytic>
	<monogr>
		<title level="j">J Cancer Res Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="757" to="767" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Role of thyroid hormone in hepatic gene regulation, chromatin remodeling, and autophagy</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ohba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Yen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2017.02.018</idno>
		<idno type="PMID">28216439</idno>
		<ptr target="https://doi.org/10.1016/j.mce.2017.02.018" />
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Farah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ohba</surname></persName>
		</author>
		<idno type="DOI">10.1080/15548627.2015.1061849</idno>
		<idno type="PMID">26103054</idno>
		<ptr target="https://doi.org/10.1080/15548627.2015.1061849" />
	</analytic>
	<monogr>
		<title level="j">Autophagy</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1341" to="1357" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor</title>
		<author>
			<persName><forename type="first">D</forename><surname>Shang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tian</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.urology.2011.12.011</idno>
		<idno type="PMID">22341602</idno>
		<ptr target="https://doi.org/10.1016/j.urology.2011.12.011" />
	</analytic>
	<monogr>
		<title level="j">Urology</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="966" to="e967" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Pu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Shun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.2353/ajpath.2010.090539</idno>
		<idno type="PMID">20395446</idno>
		<ptr target="https://doi.org/10.2353/ajpath.2010.090539" />
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="3050" to="3061" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Q</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Q</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">X</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.urolonc.2012.09.013</idno>
		<idno type="PMID">23273913</idno>
		<ptr target="https://doi.org/10.1016/j.urolonc.2012.09.013" />
	</analytic>
	<monogr>
		<title level="j">Urol Oncol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="153" to="161" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Kitzing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Pertz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Copeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grosse</surname></persName>
		</author>
		<idno type="DOI">10.1038/onc.2009.515</idno>
		<idno type="PMID">20101212</idno>
		<ptr target="https://doi.org/10.1038/onc.2009.515" />
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2441" to="2448" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells</title>
		<author>
			<persName><forename type="first">P</forename><surname>Herna ´ndez-Varas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´gp</forename><surname>Colo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´ra</forename><surname>Bartolome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Medraño-Ferna ´ndez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arellano-Sa ´nchez</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M110.189811</idno>
		<idno type="PMID">21454517</idno>
		<ptr target="https://doi.org/10.1074/jbc.M110.189811" />
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="18492" to="18504" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients</title>
		<author>
			<persName><forename type="first">T</forename><surname>Mu ¨ller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Poletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Garzia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rothley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Plaumann</surname></persName>
		</author>
		<idno type="DOI">10.1038/onc.2010.6</idno>
		<idno type="PMID">20154719</idno>
		<ptr target="https://doi.org/10.1038/onc.2010.6" />
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2393" to="23403" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">eIF5B increases ASAP1 expression to promote HCC proliferation and invasion</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.11469</idno>
		<idno type="PMID">27694689</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.11469" />
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="62327" to="62339" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway</title>
		<author>
			<persName><forename type="first">D</forename><surname>Douchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ohtsuka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ariake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Masuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kawasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kawaguchi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2015.05.023</idno>
		<idno type="PMID">26047573</idno>
		<ptr target="https://doi.org/10.1016/j.canlet.2015.05.023" />
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="132" to="140" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ariake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ohtsuka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Motoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Douchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rikiyama</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2012.06.012</idno>
		<idno type="PMID">22750095</idno>
		<ptr target="https://doi.org/10.1016/j.canlet.2012.06.012" />
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="99" to="107" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Characterization of the Xenopus homolog of an immediate early gene associated with cell activation: sequence analysis and regulation of its expression by thyroid hormone during amphibian metamorphosis</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sedgwick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">B</forename><surname>Shi</surname></persName>
		</author>
		<idno type="DOI">10.1038/cr.1997.19</idno>
		<idno type="PMID">9444397</idno>
		<ptr target="https://doi.org/10.1038/cr.1997.19" />
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="179" to="193" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Thyroid hormone administration induces rat liver Nrf2 activation: suppression by N-acetylcysteine pretreatment</title>
		<author>
			<persName><forename type="first">P</forename><surname>Romanque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cornejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Valde ´s</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Videla</surname></persName>
		</author>
		<idno type="DOI">10.1089/thy.2010.0322</idno>
		<idno type="PMID">21563917</idno>
		<ptr target="https://doi.org/10.1089/thy.2010.0322" />
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="655" to="662" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Thyroid hormone responsive genes in cultured human fibroblasts</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Moeller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dumitrescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Meltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Refetoff</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2004-1768</idno>
		<idno type="PMID">15507505</idno>
		<ptr target="https://doi.org/10.1210/jc.2004-1768" />
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="936" to="943" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">M</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Alkharouf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Malek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1128/MCB.21.19.6626-6639.2001</idno>
		<idno type="PMID">11533250</idno>
		<ptr target="https://doi.org/10.1128/MCB.21.19.6626-6639" />
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="6626" to="6639" />
			<date type="published" when="2001">2001. 2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine</title>
		<author>
			<persName><surname>Stoddard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Eskin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Johannes</surname></persName>
		</author>
		<idno type="PMID">18645607</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Med Sci</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="189" to="196" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ambrosio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Stefano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Girolamo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Salvatore</forename><forename type="middle">D</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2017.06.014</idno>
		<idno type="PMID">28630021</idno>
		<ptr target="https://doi.org/10.1016/j.mce.2017.06.014" />
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling</title>
		<author>
			<persName><forename type="first">V</forename><surname>Catalano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dentice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ambrosio</forename><forename type="middle">R</forename><surname>Luongo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Carollo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Benfante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-15-1542</idno>
		<idno type="PMID">26676745</idno>
		<ptr target="https://doi.org/10.1158/0008-5472.CAN-15-1542" />
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="1237" to="1244" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Puzianowska-Kuznicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nauman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Madej</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nauman</surname></persName>
		</author>
		<idno type="PMID">10822129</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="145" to="152" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Nongenomic actions of thyroid hormone</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Leonard</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrendo.2015.205</idno>
		<idno type="PMID">26668118</idno>
		<ptr target="https://doi.org/10.1038/nrendo.2015.205" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="111" to="121" />
			<date type="published" when="2016-02">2016 Feb</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">STAT3 signaling: anticancer strategies and challenges</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Grandis</surname></persName>
		</author>
		<idno type="DOI">10.1124/mi.11.1.4</idno>
		<idno type="PMID">21441118</idno>
		<ptr target="https://doi.org/10.1124/mi.11.1.4" />
	</analytic>
	<monogr>
		<title level="j">Mol Interv</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="18" to="26" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Horiguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Uchida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Marumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Murai</surname></persName>
		</author>
		<idno type="PMID">12131365</idno>
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="page" from="762" to="765" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reckamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hedvat</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-11-1217</idno>
		<idno type="PMID">21920898</idno>
		<ptr target="https://doi.org/10.1158/0008-5472.CAN-11-1217" />
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="6601" to="6610" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Shanmugam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rajendran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sikka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Siveen</surname></persName>
		</author>
		<idno type="DOI">10.1002/mc.22166</idno>
		<idno type="PMID">24797723</idno>
		<ptr target="https://doi.org/10.1002/mc.22166" />
	</analytic>
	<monogr>
		<title level="j">Mol Carcinog</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="971" to="985" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">A Role for Widely Interspaced Zinc Finger (WIZ) in Retention of the G9a Methyltransferase on Chromatin</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Rothbart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ait-Si-Ali</forename></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Strahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M115.654459</idno>
		<idno type="PMID">26338712</idno>
		<ptr target="https://doi.org/10.1074/jbc.M115.654459" />
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="page" from="26088" to="260102" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence</title>
		<author>
			<persName><forename type="first">F</forename><surname>Raza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Waldron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Quesne</surname></persName>
		</author>
		<idno type="DOI">10.1042/BST20150163</idno>
		<idno type="PMID">26614665</idno>
		<ptr target="https://doi.org/10.1042/BST20150163" />
	</analytic>
	<monogr>
		<title level="j">Biochem Soc Trans</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1227" to="1233" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
